Johnson & Johnson to end sale of opioids, settles NY case for $230million

Johnson & Johnson will pay $230million to resolve an opioids lawsuit, days before it was due to go to trial, in a settlement reached with New York’s attorney general Letitia James. In the agreement, J&J will end the sale of all opioid products nationwide.